1. Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes. Issue 11 (28th July 2015) Authors: Saulsberry, W. J.; Coleman, C. I.; Mearns, E. S.; Zaccaro, E.; Doleh, Y.; Sobieraj, D. M. Journal: International journal of clinical practice Issue: Volume 69:Issue 11(2015) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes. Issue 11 (28th July 2015) Authors: Saulsberry, W. J.; Coleman, C. I.; Mearns, E. S.; Zaccaro, E.; Doleh, Y.; Sobieraj, D. M. Journal: International journal of clinical practice Issue: Volume 69:Issue 11(2015) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta‐analysis. Issue 12 (17th July 2015) Authors: Mearns, E. S.; Saulsberry, W. J.; White, C. M.; Kohn, C. G.; Lemieux, S.; Sihabout, A.; Salamucha, I.; Coleman, C. I. Journal: Diabetic medicine Issue: Volume 32:Issue 12(2015:Dec.) Page Start: 1530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta‐analysis of randomized controlled trials. (11th May 2015) Authors: Mearns, E. S.; Coleman, C. I.; Patel, D.; Saulsberry, W. J.; Corman, A.; Li, D.; Hernandez, A. V.; Kohn, C. G. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 6(2015:Jun.) Page Start: 1043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P766: CLINICAL OUTCOMES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING HYPOMETHYLATING AGENTS: A LARGE POPULATION-BASED ANALYSIS. (23rd June 2022) Authors: Zeidan, A. M.; Mearns, E. S.; Ng, C.; Shah, A.; Lamarre, N.; Yellow-Duke, A.; Alrawashdh, N.; Yang, B.; Cheng, W.; Bui, C. N.; Svensson, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗